Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Carcinoma, Basal Cell 6Carcinoma, Non-Small-Cell Lung 3Pancreatic Neoplasms 2Mycosis Fungoides 2Keratosis, Actinic 2Basal Cell Nevus Syndrome 2Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sezary Syndrome 1Salivary Gland Neoplasms 1Pleural Diseases 1Pain 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Mesothelioma, Malignant 1Lymphoma, T-Cell, Cutaneous 1Esthesioneuroblastoma, Olfactory 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Adenocarcinoma, Follicular 1Adenocarcinoma of Lung 1

Interventions

3-ingenyl angelate 39Imiquimod 22Aminolevulinic Acid 22Photochemotherapy 16methyl 5-aminolevulinate 12Fluorouracil 11Diclofenac 11Gels 10Cryotherapy 6Solutions 5BF-200 ALA 5tirbanibulin 4Radiotherapy 4Prilocaine 4Lidocaine 4LEO 43204 4Petrolatum 3Ointments 3Cryosurgery 3calcipotriene 2SR-T100 2Niacinamide 2Blue Light 21-phenyl-3,3-dimethyltriazene 2tazarotene 1potassium dobesilate 1perillyl alcohol 1endonuclease V, phage T4 1dexpanthenol 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Keratosis, Actinic × 1-phenyl-3,3-dimethyltriazene × Clear all
NCT06712381 2024-12-02

Carac & PDT Combination in the Treatment Of Actinic Keratoses

Skin Laser & Surgery Specialists

Phase 1/2 Completed
60 enrolled
Dermatologic

Keratosis, Actinic

NCT01966120 2023-07-28

Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)

Biofrontera Bioscience GmbH

Phase 3 Completed
87 enrolled 21 charts
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡